A long-acting ACE inhibitor used to reduce blood pressure significantly decreased the risk for cardiovascular disease, including stroke, in normal weight, overweight and obese patients, according to research reported in Hypertension: Journal of the American Heart Association. In the Perindopril Protection Against Recurrent Stroke Study (PROGRESS), the rate of cardiovascular disease declined by more than 25 percent in normal weight, overweight and obese patient groups… (Source: Health News from Medical News Today)

Further information:

Article source

Related posts:

1. The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus – an analysis from the SCOUT lead-in period
2. Use Of Multiple Genetic Markers Not Associated With Improved Ability To Predict Risk Of Cardiovascular Disease In Women
3. Prevention Guidelines Help Predict Women’s Cardiovascular Risk
4. Racial Differences In Undiagnosed Key Stroke Risk Factor And Stroke Incidence
5. Heart Disease And Stroke Survivors Urge Congress To Increase Funding For The National Institutes Of Health